BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 30761608)

  • 1. Independent and cooperative roles of the Mek/ERK1/2-MAPK and PI3K/Akt/mTOR pathways during developmental myelination and in adulthood.
    Ishii A; Furusho M; Macklin W; Bansal R
    Glia; 2019 Jul; 67(7):1277-1295. PubMed ID: 30761608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mek/ERK1/2-MAPK and PI3K/Akt/mTOR signaling plays both independent and cooperative roles in Schwann cell differentiation, myelination and dysmyelination.
    Ishii A; Furusho M; Bansal R
    Glia; 2021 Oct; 69(10):2429-2446. PubMed ID: 34157170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Signaling by FGF Receptor 2, Not FGF Receptor 1, Regulates Myelin Thickness through Activation of ERK1/2-MAPK, Which Promotes mTORC1 Activity in an Akt-Independent Manner.
    Furusho M; Ishii A; Bansal R
    J Neurosci; 2017 Mar; 37(11):2931-2946. PubMed ID: 28193689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strength of ERK1/2 MAPK Activation Determines Its Effect on Myelin and Axonal Integrity in the Adult CNS.
    Ishii A; Furusho M; Dupree JL; Bansal R
    J Neurosci; 2016 Jun; 36(24):6471-87. PubMed ID: 27307235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ERK1/ERK2 MAPK signaling is required to increase myelin thickness independent of oligodendrocyte differentiation and initiation of myelination.
    Ishii A; Fyffe-Maricich SL; Furusho M; Miller RH; Bansal R
    J Neurosci; 2012 Jun; 32(26):8855-64. PubMed ID: 22745486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of ERK1/2 MAPK signaling in the maintenance of myelin and axonal integrity in the adult CNS.
    Ishii A; Furusho M; Dupree JL; Bansal R
    J Neurosci; 2014 Nov; 34(48):16031-45. PubMed ID: 25429144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. R-Ras1 and R-Ras2 Are Essential for Oligodendrocyte Differentiation and Survival for Correct Myelination in the Central Nervous System.
    Sanz-Rodriguez M; Gruart A; Escudero-Ramirez J; de Castro F; Delgado-García JM; Wandosell F; Cubelos B
    J Neurosci; 2018 May; 38(22):5096-5110. PubMed ID: 29720552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opposing extracellular signal-regulated kinase and Akt pathways control Schwann cell myelination.
    Ogata T; Iijima S; Hoshikawa S; Miura T; Yamamoto S; Oda H; Nakamura K; Tanaka S
    J Neurosci; 2004 Jul; 24(30):6724-32. PubMed ID: 15282275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained activation of ERK1/2 MAPK in oligodendrocytes and schwann cells enhances myelin growth and stimulates oligodendrocyte progenitor expansion.
    Ishii A; Furusho M; Bansal R
    J Neurosci; 2013 Jan; 33(1):175-86. PubMed ID: 23283332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. R-Ras GTPases Signaling Role in Myelin Neurodegenerative Diseases.
    Alcover-Sanchez B; Garcia-Martin G; Wandosell F; Cubelos B
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32824627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oligodendrocyte differentiation and signaling after transferrin internalization: a mechanism of action.
    Pérez MJ; Fernandez N; Pasquini JM
    Exp Neurol; 2013 Oct; 248():262-74. PubMed ID: 23797152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shenzhiling oral liquid protects the myelin sheath against Alzheimer's disease through the PI3K/Akt-mTOR pathway.
    Zheng M; Liu Z; Mana L; Qin G; Huang S; Gong Z; Tian M; He Y; Wang P
    J Ethnopharmacol; 2021 Oct; 278():114264. PubMed ID: 34082015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fbxw7 Limits Myelination by Inhibiting mTOR Signaling.
    Kearns CA; Ravanelli AM; Cooper K; Appel B
    J Neurosci; 2015 Nov; 35(44):14861-71. PubMed ID: 26538655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myelination and mTOR.
    Figlia G; Gerber D; Suter U
    Glia; 2018 Apr; 66(4):693-707. PubMed ID: 29210103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Akt Regulates Axon Wrapping and Myelin Sheath Thickness in the PNS.
    Domènech-Estévez E; Baloui H; Meng X; Zhang Y; Deinhardt K; Dupree JL; Einheber S; Chrast R; Salzer JL
    J Neurosci; 2016 Apr; 36(16):4506-21. PubMed ID: 27098694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of mTOR and Erk1/2 signaling to regulate oligodendrocyte differentiation.
    Dai J; Bercury KK; Macklin WB
    Glia; 2014 Dec; 62(12):2096-109. PubMed ID: 25060812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Akt signals through the mammalian target of rapamycin pathway to regulate CNS myelination.
    Narayanan SP; Flores AI; Wang F; Macklin WB
    J Neurosci; 2009 May; 29(21):6860-70. PubMed ID: 19474313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oligogenesis in the "oligovascular unit" involves PI3K/AKT/mTOR signaling in hypoxic-ischemic neonatal mice.
    Wang X; Wang Y; Wang L; Shi S; Yang C; Jiang W; Luan Z; Liu L; Yao R
    Brain Res Bull; 2020 Feb; 155():81-91. PubMed ID: 31785301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholesterol Biosynthesis Supports Myelin Gene Expression and Axon Ensheathment through Modulation of P13K/Akt/mTor Signaling.
    Mathews ES; Appel B
    J Neurosci; 2016 Jul; 36(29):7628-39. PubMed ID: 27445141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanistic Target of Rapamycin Regulates the Oligodendrocyte Cytoskeleton during Myelination.
    Musah AS; Brown TL; Jeffries MA; Shang Q; Hashimoto H; Evangelou AV; Kowalski A; Batish M; Macklin WB; Wood TL
    J Neurosci; 2020 Apr; 40(15):2993-3007. PubMed ID: 32139584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.